发明名称 SELECTION OF PERSONALIZED CANCER THERAPY REGIMENS USING INTERFERING RNA FUNCTIONAL SCREENING
摘要 Methods for screening cells obtained from a subject for aberrant kinase activity are disclosed. The methods include placing cells isolated from the subject in contact with a set of siRNAs, wherein each individual siRNA is at an addressable location on the array and specifically inhibits expression of a tyrosine kinase. The siRNA is introduced into the blood cells or bone marrow cells by electroporation. After introduction of the siRNA, the cells are then assayed for proliferation and/or viability as compared to a control. A decreased proliferation and/or viability of the cells as compared to a control identifies a siRNA that inhibits the proliferation and/or viability of the cells, thus identifying the tyrosine kinase having aberrant tyrosine kinase activity in the subject.
申请公布号 US2009312194(A1) 申请公布日期 2009.12.17
申请号 US20080271629 申请日期 2008.11.14
申请人 OREGON HEALTH & SCIENCE UNIVERSITY 发明人 TYNER JEFFREY W.;DRUKER BRIAN J.;LORIAUX MARC;LUTTROPP MARY V.
分类号 C40B30/06 主分类号 C40B30/06
代理机构 代理人
主权项
地址